Live Breaking News & Updates on Capital Equity Investment Company Limited

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding
News provided by
Share this article
Share this article
SUZHOU, China, May 18, 2021 /PRNewswire/ GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter GeneQuantum ) announced the completion of Series C fund raising of several hundreds of millions RMB. This series of fund raising is led by China Life Private Equity Investment, jointly by PICC Capital Equity Investment, Sunshine Guojian and Suzhou Wuzhong Biomedicine Industrial Park Investment. The current fund raising will provide a solid financial foundation to GeneQuantum for its global clinical development and pipeline expansion of next generation site-specific bioconjugates.
Since its establishment, GeneQuantum has focused on the development of innovative bioconjugate drugs represented by Antibody-Drug-Conjugate (ADC). We possess highly differentiated ADC technology platforms, including enzyme catalyzed site-specific conjugation technol ....

Guo Jian , Gang Qin , Lerming Pharma , Leidi Zhang , Innovation Fund , Healthcare Fund , Investment Co Ltd , Genequantum Healthcare Suzhou Co Ltd , Rendong Holding , Suzhou Direct Investment Fund , China Life Health Foundation , Capital Equity Investment Company Limited , China Life Healthcare Fund , Sector Fund , Technological Development Zone , Wuzhong Biomedicine Industrial Park Investment Co Ltd , Prnewswire Genequantum Healthcare Suzhou Co Ltd , China Life Health Fund , Quantum Healthcare , China Life Private Equity Investment , Equity Investment , Sunshine Guojian , China Life , Life Health Foundation , Genequantum Healthcare , Life Health Fund ,